本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Third Harmonic Bio, Inc.

5.38
0.0000
成交量:- -
成交額:- -
市值:2.43億
市盈率:-4.32
高:5.38
開:5.38
低:5.38
收:5.38
52周最高:16.02
52周最低:3.18
股本:4,512.78萬
流通股本:1,560.34萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.2457
每股收益(LYR):-1.0896
淨資產收益率:-19.94%
總資產收益率:-14.60%
市淨率:0.89
市盈率(LYR):-4.94

資料載入中...

2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans